Cargando…

Serum lipid profile as a marker of liver impairment in hepatitis B Cirrhosis patients

BACKGROUND: Chronic HBV infection is a major cause of Cirrhosis and an important risk factor to develop hepatocellular carcinoma. The study is conducted to find out the changes in the lipid metabolism of HBV-cirrhosis patients. METHODS: In the present study, serum lipid profiles of patients with HBV...

Descripción completa

Detalles Bibliográficos
Autores principales: Arain, Sadia Qamar, Talpur, Farah Naz, Channa, Naseem Aslam, Ali, Muhammad Shahbaz, Afridi, Hassan Imran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333387/
https://www.ncbi.nlm.nih.gov/pubmed/28249586
http://dx.doi.org/10.1186/s12944-017-0437-2
_version_ 1782511695590064128
author Arain, Sadia Qamar
Talpur, Farah Naz
Channa, Naseem Aslam
Ali, Muhammad Shahbaz
Afridi, Hassan Imran
author_facet Arain, Sadia Qamar
Talpur, Farah Naz
Channa, Naseem Aslam
Ali, Muhammad Shahbaz
Afridi, Hassan Imran
author_sort Arain, Sadia Qamar
collection PubMed
description BACKGROUND: Chronic HBV infection is a major cause of Cirrhosis and an important risk factor to develop hepatocellular carcinoma. The study is conducted to find out the changes in the lipid metabolism of HBV-cirrhosis patients. METHODS: In the present study, serum lipid profiles of patients with HBV-cirrhosis were assessed by utilizing micro-lab and gas chromatography, while risk factors for transmission of HBV-cirrhosis studied through the standard questionnaire. RESULTS: The epidemiological and etiological risk factors strongly associated with HBV-cirrhosis patients compared to controls, included as family history, shave from the barber, blood transfusion (without proper screening), mutual sharing of household contents, positive surgery history, and dental treatment. The HBV-cirrhosis patients have significantly lower level (p < 0.001) of lipid profile including total cholesterol (96.65 mg/dl), TAG (82.85 mg/dl), VLDL-C (16.57 mg/dl), LDL-C (68.27 mg/dl), HDL-C (27 mg/dl) and total lipid (424.76 mg/dl) in comparison to controls, indicating hypolipidemia in patients. The MELD score indicated mild prognostic values of the hepatic function for the study group. The result of total fatty acid composition of HBV-cirrhotic patients with comparison of control subjects reveals that palmitic (24.54 g/100 g) and palmitoleic acid (4.65 g/100 g) were significantly (p < 0.05) higher whereas eicosatrienoic (0.09 g/100 g), arachidonic (3.57 g/100 g), linoleic (22.75 g/100 g) and α-linolenic acid (0.12 g/100 g) were significantly lower. Marker for stearoyl-CoA desaturase (SCD = ∆9-desaturase) activity i.e. palmitoleic: palmitic (0.2) and oleic: stearic acid (1.5) ratios, originated higher in HBV-cirrhotic patients, while PUFA: SFA (0.6) was lower in HBV-cirrhosis patients as compared with control subjects. The serum SFA and MUFA were increased while PUFA were reduced in both total and free form. CONCLUSION: Present study concluded that hypolipidemia observed in HBV-cirrhosis patients, MELD were found to be independent predictors of survival and alteration in fatty acid composition, possibly due to impairment in fatty acid metabolism by enzymatic elongation and desaturation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12944-017-0437-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5333387
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53333872017-03-06 Serum lipid profile as a marker of liver impairment in hepatitis B Cirrhosis patients Arain, Sadia Qamar Talpur, Farah Naz Channa, Naseem Aslam Ali, Muhammad Shahbaz Afridi, Hassan Imran Lipids Health Dis Research BACKGROUND: Chronic HBV infection is a major cause of Cirrhosis and an important risk factor to develop hepatocellular carcinoma. The study is conducted to find out the changes in the lipid metabolism of HBV-cirrhosis patients. METHODS: In the present study, serum lipid profiles of patients with HBV-cirrhosis were assessed by utilizing micro-lab and gas chromatography, while risk factors for transmission of HBV-cirrhosis studied through the standard questionnaire. RESULTS: The epidemiological and etiological risk factors strongly associated with HBV-cirrhosis patients compared to controls, included as family history, shave from the barber, blood transfusion (without proper screening), mutual sharing of household contents, positive surgery history, and dental treatment. The HBV-cirrhosis patients have significantly lower level (p < 0.001) of lipid profile including total cholesterol (96.65 mg/dl), TAG (82.85 mg/dl), VLDL-C (16.57 mg/dl), LDL-C (68.27 mg/dl), HDL-C (27 mg/dl) and total lipid (424.76 mg/dl) in comparison to controls, indicating hypolipidemia in patients. The MELD score indicated mild prognostic values of the hepatic function for the study group. The result of total fatty acid composition of HBV-cirrhotic patients with comparison of control subjects reveals that palmitic (24.54 g/100 g) and palmitoleic acid (4.65 g/100 g) were significantly (p < 0.05) higher whereas eicosatrienoic (0.09 g/100 g), arachidonic (3.57 g/100 g), linoleic (22.75 g/100 g) and α-linolenic acid (0.12 g/100 g) were significantly lower. Marker for stearoyl-CoA desaturase (SCD = ∆9-desaturase) activity i.e. palmitoleic: palmitic (0.2) and oleic: stearic acid (1.5) ratios, originated higher in HBV-cirrhotic patients, while PUFA: SFA (0.6) was lower in HBV-cirrhosis patients as compared with control subjects. The serum SFA and MUFA were increased while PUFA were reduced in both total and free form. CONCLUSION: Present study concluded that hypolipidemia observed in HBV-cirrhosis patients, MELD were found to be independent predictors of survival and alteration in fatty acid composition, possibly due to impairment in fatty acid metabolism by enzymatic elongation and desaturation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12944-017-0437-2) contains supplementary material, which is available to authorized users. BioMed Central 2017-03-01 /pmc/articles/PMC5333387/ /pubmed/28249586 http://dx.doi.org/10.1186/s12944-017-0437-2 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Arain, Sadia Qamar
Talpur, Farah Naz
Channa, Naseem Aslam
Ali, Muhammad Shahbaz
Afridi, Hassan Imran
Serum lipid profile as a marker of liver impairment in hepatitis B Cirrhosis patients
title Serum lipid profile as a marker of liver impairment in hepatitis B Cirrhosis patients
title_full Serum lipid profile as a marker of liver impairment in hepatitis B Cirrhosis patients
title_fullStr Serum lipid profile as a marker of liver impairment in hepatitis B Cirrhosis patients
title_full_unstemmed Serum lipid profile as a marker of liver impairment in hepatitis B Cirrhosis patients
title_short Serum lipid profile as a marker of liver impairment in hepatitis B Cirrhosis patients
title_sort serum lipid profile as a marker of liver impairment in hepatitis b cirrhosis patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333387/
https://www.ncbi.nlm.nih.gov/pubmed/28249586
http://dx.doi.org/10.1186/s12944-017-0437-2
work_keys_str_mv AT arainsadiaqamar serumlipidprofileasamarkerofliverimpairmentinhepatitisbcirrhosispatients
AT talpurfarahnaz serumlipidprofileasamarkerofliverimpairmentinhepatitisbcirrhosispatients
AT channanaseemaslam serumlipidprofileasamarkerofliverimpairmentinhepatitisbcirrhosispatients
AT alimuhammadshahbaz serumlipidprofileasamarkerofliverimpairmentinhepatitisbcirrhosispatients
AT afridihassanimran serumlipidprofileasamarkerofliverimpairmentinhepatitisbcirrhosispatients